Latest IPO Information

Gujarat Kidney And Super Speciality Ltd. IPO

IPO Date: Dec 22 to Dec 24 2025

Listing Date: Dec 30 2025

Objective

1. Proposed acquisition of “Parekhs Hospital Private Limited” at Ahmedabad
2. Part payment of purchase consideration for the already acquired hospital i.e. “Ashwini Medical Centre”
3. Funding of capital expenditure requirements of our Company towards setting up of a new hospital exclusively for women’s health care in Vadodara;
4. Buying robotics equipment for our hospital Gujarat Kidney & Super Speciality hospital at Vadodara location
5. Full or part repayment and/or prepayment of certain outstanding secured borrowings availed by our Company and
6. Funding inorganic growth through unidentified acquisitions and General Corporate Purposes.

IPO Details

Face Value ₹ 2.00 Per Share
Issue Size ₹ 142.85 - 150.79 Cr
Price Band ₹ 108.00 - ₹ 114.00 Per Share
Market LOT 128 shares
Issue Type Book building

About Company

We are one of the regional healthcare companies located in the central region of state of Gujarat and operate achain of mid-sized multispeciality hospitals, providing integrated healthcare services, with a focus on secondaryand tertiary care. As of March 20, 2025, on a consolidated basis, we operate six (06) multispeciality hospitals and(03) pharmacies operating within our Hospitals, Gujarat Kidney and Superspeciality Hospital (Vadodara), GujaratMultispeciality Hospital (Godhra), Raj Palmland Hospital Private Limited (Bharuch), M/s. Surya Hospital andICU (Borsad), Gujarat Surgical Hospital (Va .... dodara), Ashwini Medical Centre (Anand) and Ashwini MedicalStore (Anand) with a total bed capacity of 400 beds, approved bed capacity of 355 beds and operational bedcapacity of 250 beds. We endeavour to address all the needs of our patients through our healthcare services. Read More
Address

Plot No. 1, City Sarve No. 1537 / A Jetalpur Road, Gokak Mill Compound Alkapuri

City

Vadodara

State

Gujarat

Pincode

390020

Phone

0265 2984800

Email

info@gujaratsuperspecialityhospital.com

Website

www.gujaratsuperspecialityhospital.com

About IPO

Listed At BSE/NSE
Lead Manager Nirbhay Capital Services Pvt Ltd.
Promoters
Pragnesh Yashwantsinh Bharpoda
Bhartiben Pragnesh Bharpoda
Yashwantsingh Motisinh Bharpoda
Anitaben Yashwantsinh Bharpoda

Promoter's Holding

Registrar

MUFG Intime India Pvt Ltd.

rnt.helpdesk@in.mpms.mufg.com
https://in.mpms.mufg.com/

Latest News

Aug
24
2026
EQUITY Posted on Aug 24th 2026

Gujarat Kidney and Super Speciality informs about voting results of postal ballot

Gujarat Kidney and Super Speciality has informed that this is with reference to Postal Ballot Notice dated 09.07.2026, seeking approval of shareholders of the Company by way of Postal Ballot (remote e-voting) on the special resolution: Variation in the Objects / terms of utilisation of the Initial Public Offering (‘IPO’) proceeds. The voting on Postal Ballot concluded at 5.00 pm (IST) on Saturday, August 22, 2026 and the Scrutinizer has submitted their report on Postal Ballot (remote e-voting) on the same day. Pursuant to Regulation 44(3) of SEBI (LODR) Regulations 2015, the Company has informed that the resolution has been passed with requisite majority. In this regard, it has attached the voting results of the Postal Ballot in compliance with Regulation 44(3) of SEBI (LODR) Regulations 2015 alongwith the report of Scrutinizer on remote e-voting annexed as Annexure - A. The above information is also available on the company’s website at www.gujaratsuperspecialityhospital.com.

The above information is a part of company’s filings submitted to BSE.  
Read More
Jul
23
2026
EQUITY Posted on Jul 23rd 2026

Gujarat Kidney and Super Specialty submit notice of postal ballot.

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Gujarat Kidney and Super Specialty has enclosed the clippings of newspaper publication in respect of the Notice of Postal Ballot, published in the following newspapers on Thursday, July 23, 2026: The Financial Express-English (Ahmedabad edition); Gujarat Mitra- Gujarati (Vadodara Edition).
The above information is a part of company's filings submitted to BSE.
Read More
Oct
3
2026
EQUITY Posted on Oct 3rd 2026

Neo Infracon informs about updates

Neo Infracon has informed that Sonalben Kanabar (ACS 58808) has today conveyed her decision to resign from the post of Company Secretary and Compliance Officer of the Company, due to her personal reasons. She will continue to discharge her duties as the Company Secretary and Compliance Officer of the Company, until the close of business hours on Saturday, 31st October 12026 to facilitate smooth transition. The Company has accepted her resignation. Detailed information as required under SEBI (LODR) Regulations, 2015 read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated 13 July 2023 in respect of aforesaid resignation are given in ‘Annexure A’ to this letter. The letter of resignation along with the reason for resignation is annexed as ‘Annexure B’.
The above information is a part of company’s filings submitted to BSE.
Read More
Oct
3
2026
EQUITY Posted on Oct 3rd 2026

Mangalam Drugs & Organics informs about press release

Mangalam Drugs & Organics has informed that it enclosed intimation under Regulation 30 of SEBI (LODR), 2015 for Newspaper publication regarding issuance of postal ballot notice for appointment of Prabhakar Raghunath Zavar as Independent Director.
The above information is a part of company’s filings submitted to BSE.
Read More
Oct
3
2026
EQUITY Posted on Oct 3rd 2026

United Polyfab Gujarat informs about voting results

United Polyfab Gujarat has informed that it enclosed details of voting result inclusive of remote e-voting and e-voting during AGM of the Company held on Tuesday, September 29, 2026 through Video Conferencing (VC) / Other Audio Video Means (OAVM):Voting results as required under Regulation 44 of the Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations) ; Consolidated Report of Scrutinizer dated October 01, 2026, for remote e-voting and e-voting during the AGM, pursuant to Section 108 of the Companies Act, 2013 read with Rule 20(4)(xi) and Rule 21(2) of the Companies (Management and Administration) Rules, 2014.
The above information is a part of company’s filings submitted to BSE.
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the issue size of Gujarat Kidney And Super Speciality Ltd. IPO?

The issue size of Gujarat Kidney And Super Speciality Ltd. IPO is ₹142.85 - 150.79 crore.

The Gujarat Kidney And Super Speciality Ltd. IPO opens for subscription on 2025-12-22 and closes on 2025-12-24.

The price range of Gujarat Kidney And Super Speciality Ltd. IPO is ₹108.00 to ₹114.00.

The lot size of Gujarat Kidney And Super Speciality Ltd. IPO is 128 shares.

The registrar of Gujarat Kidney And Super Speciality Ltd. IPO is MUFG Intime India Pvt Ltd..

Gujarat Kidney And Super Speciality Ltd. IPO will be listed on BSE/NSE .

You will typically receive a confirmation message or notification from your broker or trading platform shortly after placing your IPO order. This confirms that your application has been submitted successfully. You can also check the order status in the IPO section of your trading account or app.

Apply early with valid UPI and PAN before 2025-12-24 to increase your chances.

The listing date of Gujarat Kidney And Super Speciality Ltd. IPO is 2025-12-30.

An Initial Public Offering (IPO) is when a private company sells shares to the public for the first time, enabling investors to purchase these shares and gain partial ownership in the business. For instance, if a well-known tech firm wants to grow and requires additional funds, it might choose to go public through an IPO. During this process, investors can buy shares, and the company’s stock starts trading on the stock exchange on the day of the IPO listing.

Investors can apply for an IPO through their bank or brokerage account. Many trading platforms have a specific section for IPOs where users can submit their applications online.

The primary market is where shares are offered to the public for the first time via an IPO. After the IPO, shares are traded on the secondary market (stock exchange), where existing shareholders can sell to new buyers.

Investing in an IPO offers the opportunity to become an early investor in companies with high growth potential, at a price which may be lower than their post-listing market value. It provides a chance to participate in the company's growth journey from its early stages. However, IPO investments also come with inherent risks, such as market volatility and uncertainties about the company's future performance.

The price of an IPO is established through a systematic process known as "book building." In this method, investors bid within a given price range, and the final price is set based on demand and market conditions. Several factors play a crucial role in determining the IPO price, including:

Past Financial Performance: Evaluating the company's revenue, profits, and financial stability over time

Growth Potential: Assessing future prospects based on the company's business model and market opportunities

Industry Peers: Comparing valuation metrics with similar companies in the same sector

Larger Industry Picture: Analysing overall industry trends and economic conditions that could impact the company's performance

The lock-in period for IPO shares refers to a duration during which specific investors are restricted from selling their shares post-listing. This period varies based on the type of investor:

Promoters: The lock-in period for promoters ranges from 6 months to 18 months, ensuring their commitment to the company's long-term growth

Anchor Investors: Typically, anchor investors face a shorter lock-in period of 30 to 90 days, depending on regulatory norms and the specific IPO

IPOs can be volatile and may not perform as expected in the short term. Investors risk losing capital if the stock price drops after listing, especially if the company does not meet its growth projections.

Information on upcoming IPOs is often available through brokerage platforms, financial news sites, and regulatory bodies like SEBI, which publishes details on companies going public. You can also get these details under the upcoming IPO section on Bajaj Markets.

Eligibility for an IPO typically includes:

Retail Investors: Individuals who invest in smaller amounts, usually under the “retail investor” category, with certain limits

Qualified Institutional Buyers (QIBs): Entities like mutual funds, banks, and insurance companies, who invest large sums

Non-Institutional Investors (NIIs): High-net-worth individuals or entities investing above the retail threshold

Investors must have a Demat and trading account to apply, and in some cases, certain financial or residency qualifications may apply depending on local regulations.

SME (Small and Medium Enterprise) IPOs generally carry higher risk but may provide significant growth potential. Investors should research the company’s stability, financials, and sector risks, as SME stocks can be more volatile compared to large-cap companies.

View More

Invalid Mobile Number

Invalid Full Name

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore